Pyrazolate-Bridged CoII Dimers with H-Bond Donors
(Pz-C3-CH2N), 49.95 (NH-C(CH3)3), 38.19 (CH2CH2NH), 32.28
(Pz-C5-C(CH3)3), 30.67 (Pz-C5-C(CH3)3), 29.76 (NH-C(CH3)3),
29.65 (C3-thp), 25.17 (C5-thp), 22.81 (C4-thp).
pyrazole (H9PiPrbuam; 0.100 g, 0.157 mmol), KH (0.038 g, 0.94
mmol), CoCl2 (0.041 g, 0.31 mmol), H2O (0.0028 g, 0.16 mmol),
and tetrapropylammonium chloride (0.070 g, 0.31 mmol) to yield
a purple solid, 0.17 g (94%). X-ray-quality crystals were obtained
by vapor diffusion of diethyl ether in a DMA solution of the isolated
3-{Bis[(N′-tert-butylureayl)-N-ethyl]aminomethyl}-5-tert-bu-
tyl-1H-pyrazole (H5PtBuuam). To a solution of 2 (6.49 g, 12.4
mmol) in absolute ethanol (118 mL) was added 67 mL of freshly
prepared ethanolic HCl, and the reaction mixture was stirred at room
temperature for 18 h. The solvent was removed under reduced
pressure to obtain an off-white solid. Next, the solid was dissolved
in water (100 mL), and 100 mL of a saturated sodium carbonate
solution was added, resulting in a white precipitate. The pH of the
aqueous solution was g8. The precipitated product was then
extracted with three 200 mL portions of dichloromethane, and the
combined organic layer was dried with sodium sulfate. The mixture
was filtered, and the filtrate was concentrated under reduced
pressure to yield an off-white solid, 5.34 g (98%). X-ray-quality
crystals were obtained by slow evaporation of a CHCl3 solution of
the product. Mp: 115-117 °C. HRMS (ESI, m/z): 438.3564 [M+].
Exact mass calcd for C22H44N7O2 [M + H]: 438.3556. IR (KBr,
cm-1): ν(NH) 3369, ν(NH) 3296, ν(NH) 3214, ν(CO) 1640,
ν(NH) 1561. 1H NMR (CDCl3): δ 5.95 (s, 1H, Pz-H4), 5.72 (bs,
2H, CH2NH-C(O)), 5.16 (s, 2H, NH-C(CH3)3), 3.61 (s, 2H,
Pz-C3-CH2), 3.17 (bs, 4H, CH2CH2NH), 2.52 (t, J ) 5.0 Hz,
4H, NCH2CH2), 1.33 (s, 18H, NH-C(CH3)3), 1.30 (s, 9H,
Pz-C5-C(CH3)3). 13C NMR (CDCl3): δ 159.18 (C(O)), 101.60
(Pz-C4), 55.06 (NCH2CH2), 51.11 (NH-C(CH3)3), 50.46
(Pz-C3-CH2N), 38.17 (CH2CH2NH), 31.94 (Pz-C5-C(CH3)3),
30.88 (Pz-C5-C(CH3)3), 30.01 (NH-C(CH3)3). Note: Quaternary
carbons Pz-C3 and Pz-C5 are not observed by 13C NMR.
Complex Synthesis. Tetrapropylammonium or Tetraethyl-
ammonium µ-Hydroxo-µ-{3,5-bis{bis[(N′-tert-butylureaylato)-
N-ethyl]aminatomethyl}-1H-pyrazolato}dicobaltate(II) ([nPr4N]2-
[CoII H4PtBubuam(µ-OH)]) or ([Et4N]2[CoII H4PtBubuam(µ-OH)]).
metal salt. Anal. Calcd (found) for [nPr4N]2[CoII H4PiPrbuam(µ-
2
OH)]‚0.1CH2Cl2, C53.1H110.2Cl0.2Co2N14O5: C, 55.46 (55.98); H,
9.66 (9.24); N, 17.05 (16.60). IR (Nujol, cm-1): ν(OH) 3612,
ν(NH) 3348, ν(CO) 1637, 1582. UV/vis (DMA): λmax, nm (ꢀ, M-1
cm-1) 508 (sh), 560 (250), 847 (37).
Tetrapropylammonium or Tetraethylammonium µ-1,3-Acet-
amidato-µ-{3,5-bis{bis[(N′-tert-butylureaylato)-N-ethyl]aminato-
methyl}-1H-pyrazolato}dicobaltate(II) ([nPr4N]2[CoII H4PtBubuam-
2
(µ-1,3-OC(NH)CH3)]) or ([Et4N]2[CoII2H4PtBubuam(µ-1,3-OC-
(NH)CH3)]). A solution of H9PtBubuam (0.100 g, 0.144 mmol) in
anhydrous DMA (5 mL) was treated with solid KH (0.035 g, 0.86
mmol) under an argon atmosphere. After gas evolution ceased, solid
CoCl2 (0.037 g, 0.29 mmol) was added. The resulting turquoise-
blue solution was stirred for 30 min. Next, acetamide (0.009 g,
0.14 mmol) was added, resulting in a violet solution while being
stirred for an additional 30 min. Tetrapropylammonium chloride
(0.064 g, 0.29 mmol) or tetraethylammonium chloride (0.048 g,
0.29 mmol) was then added and stirred for 1 h. The solvent was
removed under reduced pressure at room temperature, and the
resulting solid residue was washed with diethyl ether and dried
under vacuum to afford a violet powder. The powder was then
dissolved in anhydrous CH2Cl2, and the insoluble KCl was fil-
tered using a fine-porosity glass frit. The solvent was evaporated
from the filtrate under reduced pressure to afford a violet solid,
0.19 g. X-ray-quality crystals were obtained by vapor diffusion of
diethyl ether in a DMA solution of the isolated metal salt. Anal.
Calcd (found) for [Et4N]2[CoII H4PtBubuam(µ-1,3-OC(NH)CH3)],
2
C51H105Co2N15O5: C, 54.38 (54.57); H, 9.40 (9.22); N, 18.65
2
2
(18.34). [nPr4N]2[CoII H4PtBubuam(µ-1,3-OC(NH)CH3)]. IR (Nujol,
A solution of 3,5-bis{bis[(N′-tert-butylureayl)-N-ethyl]amino-
methyl}-1H-pyrazole (H9PtBubuam; 0.100 g, 0.144 mmol) in
anhydrous DMA (5 mL) was treated with solid KH (0.035 g, 0.86
mmol) under an argon atmosphere. After gas evolution ceased, solid
CoCl2 (0.037 g, 0.29 mmol) was added. The resulting turquoise-
blue solution was stirred for 30 min. Ultrapure H2O (0.0026 g, 0.14
mmol) was added by microsyringe, resulting in a purple solution,
with stirring continued for an additional 30 min. Tetrapropylam-
monium chloride (0.064 g, 0.29 mmol) or tetraethylammonium
chloride (0.048 g, 0.29 mmol) was then added and stirred for 1 h.
The solvent was removed under reduced pressure at room temper-
ature, and the resulting solid residue was washed with diethyl ether
and dried under vacuum to afford a purple powder. The powder
was then dissolved in anhydrous CH2Cl2, and the insoluble KCl
was filtered using a fine-porosity glass frit. The solvent was
evaporated from the filtrate under reduced pressure to afford a
purple solid, 0.18 g (99+%). X-ray-quality crystals were obtained
by vapor diffusion of diethyl ether in a DMA solution of the isolated
2
cm-1): ν(NH) 3406, 3304, ν(CO) 1639, 1583, ν(NCO) 1539, 1516.
UV/vis (DMA): λmax, nm (ꢀ, M-1 cm-1) 484 (sh), 542 (240), 718
(40).
Tetrapropylammonium µ-1,3-Acetamidato-µ-{3,5-bis{bis[(N′-
isopropylureaylato)-N-ethyl]aminatomethyl}-1H-pyrazolato}-
dicobaltate(II) ([nPr4N]2[CoII2H4PiPrbuam(µ-1,3-OC(NH)CH3)]).
This compound was prepared by the same route as [nPr4N]2-
[CoII H4PtBubuam(µ-1,3-OC(NH)CH3)] using H9PiPrbuam (0.100
2
g, 0.157 mmol), KH (0.038 g, 0.94 mmol), CoCl2 (0.041 g, 0.31
mmol), acetamide (0.009 g, 0.16 mmol), and tetrapropylammon-
ium chloride (0.070 g, 0.31 mmol) to yield a violet solid, 0.19 g
(99+%). X-ray-quality crystals were obtained by vapor diffusion
of diethyl ether in a DMA solution of the isolated metal salt. Anal.
Calcd (found) for [nPr4N]2[CoII H4PiPrbuam(µ-1,3-OC(NH)CH3)],
2
C55H113Co2N15O5: C, 55.87 (56.40); H, 9.63 (9.38); N, 17.77
(17.46). IR (Nujol, cm-1): ν(NH) 3415, 3289, ν(CO) 1577, ν(NCO)
1538, 1494. UV/vis (DMA): λmax, nm (ꢀ, M-1 cm-1) 480 (sh),
542 (220), 720 (34).
metal salt. Anal. Calcd (found) for [Et4N]2[CoII H4PtBubuam(µ-
2
OH)]‚0.5CH2Cl2, C49.5H103ClCo2N14O5: C, 52.72 (53.03); H, 9.21
Tetrapropylammonium µ-1,3-Acetato-µ-{3,5-bis{bis[(N′-tert-
butylureaylato)-N-ethyl]aminatomethyl}-1H-pyrazolato}di-
cobaltate(II) ([nPr4N]2[CoII2H4PtBubuam(µ-1,3-OAc)]). A solution
of H9PtBubuam (0.100 g, 0.144 mmol) in anhydrous DMA (5 mL)
was treated with solid KH (0.029 g, 0.72 mmol) under an argon
atmosphere. After gas evolution ceased, solid Co(OAc)2 (0.051 g,
0.29 mmol) was added. The resulting violet solution was stirred
for 30 min. Tetrapropylammonium chloride (0.064 g, 0.29 mmol)
was then added and stirred for 1 h. The solvent was removed under
reduced pressure at room temperature, and the resulting solid residue
was washed with diethyl ether and dried under vacuum to afford a
(8.73); N, 17.39 (17.40). Anal. Calcd (found) for [nPr4N]2-
[CoII H4PtBubuam(µ-OH)], C57H118Co2N14O5: C, 57.17 (57.26); H,
2
9.93 (9.76); N, 16.38 (15.90). IR (Nujol, cm-1): ν(OH) 3620,
ν(NH) 3352, 3294, ν(CO) 1637, 1587. UV/vis (DMA): λmax, nm
(ꢀ, M-1 cm-1) 503 (sh), 562 (260), 930 (36).
Tetrapropylammonium µ-Hydroxo-µ-{3,5-bis{bis[(N′-isopro-
pylureaylato)-N-ethyl]aminatomethyl}-1H-pyrazolato}dicobaltate-
(II) ([nPr4N]2[CoII2H4PiPrbuam(µ-OH)]). This compound was
prepared by the same route as [nPr4N]2[CoII H4PtBubuam(µ-OH)]
2
using 3,5-bis{bis[(N′-isopropylureayl)-N-ethyl]aminomethyl}-1H-
Inorganic Chemistry, Vol. 46, No. 24, 2007 10123